MS eJournal Club's webcast on interferon beta-1b versus 20 mg glatiramer acetate - Taking place on December 2, 2009

Be prepared for the live MS eJournal Club webcast—Wednesday, December 2, 2009

Please join us for DIME's Multiple Sclerosis (MS) eJournal Club, in session Wednesday, Decmeber 2, 2009, at 12:15 ET.

To assure a productive session, log on prior to the live session and download the activity materials. Log on to www.msejournalclub.org/discussion.aspx?id=5

===========================

Paul O’Connor, MD, and Michael Kaufman, MD, will discuss an article recently published in The Lancet Neurology, "250 µg or 500 µg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study." After the live discussion, join us for an interactive question-and-answer session.

We sincerely hope you will join us.

Anne H. Cross MD
Professor of Neurology
Director
John L. Trotter MS Center at Washington University and Barnes-Jewish Hospital
St. Louis, Missouri

Michael Kaufman, MD
Director, MS Center
Department of Neurology
Carolinas Medical Center
Charlotte, North Carolina

Paul O'Connor, MD
Professor of Neurology
University of Toronto
MS Clinic Director
Department of Neurology
St. Michael's Hospital
Toronto, Canada

============================================